Literature DB >> 30762463

Linezolid Consumption Facilitates the Development of Linezolid Resistance in Enterococcus faecalis in a Tertiary-Care Hospital: A 5-Year Surveillance Study.

Bing Bai1,2, Kaitao Hu1,2, Jun Zeng3, Weiming Yao1,2, Duoyun Li1,2, Zhangya Pu1,2, Zhong Chen1,2, Hang Cheng1,2, Jinxin Zheng1,2,4, Weiguang Pan1,2, Zhiwei Lin1,2,4, Lixia Xie1,2,5, Qiwen Deng1,2, Zhijian Yu1,2,5.   

Abstract

Although case reports and clinical studies of linezolid (LZD)-resistant Enterococcus faecalis (LREF) have gradually increased in recent years, the relationship between LZD resistance and antibiotic consumption in hospital settings still remains unclear. In this study, we aimed to investigate the dynamic relationship between the yearly detection frequency of LREF clinical isolates and yearly consumption of LZD and vancomycin (VCM) over a 5-year period in a Chinese hospital setting. Antibiotic consumption data (LZD and VCM) from 2011 to 2015 were obtained from a computerized database and recalculated as the defined daily doses (DDDs) per 100 bed-days (DBD). All 268 E. faecalis clinical isolates were retrospectively collected from 2011 to 2015 in this hospital. LZD resistance mechanism and multilocus sequence typing of E. faecalis were determined by PCR. The annual detection frequency of LREF clinical isolates tested in this hospital was shown with 1.89% (1/53), 2% (1/50), 2.04% (1/49), 0% (0/45), and 7.04% (5/71), respectively, and the detection frequency of LZD-nonsusceptible E. faecalis (LNSEF; n = 59, including LZD-resistant and intermediate isolates) was determined with 26.42% (14/53), 34% (17/50), 16.33% (8/49), 22.22% (10/45), and 14.08% (10/71), respectively. Spearman correlation analysis revealed that LZD DBD significantly correlated positively with the detection frequency of LREF (r = 0.886, p = 0.019). Moreover, VCM DBD significantly correlated positively with the frequency of LNSEF (r = 0.943, p = 0.005). Furthermore, the detection frequency of optrA-positive E. faecalis also correlated positively with high LZD consumption load in this hospital setting. Conclusively, high LZD consumption load facilitates the development of LZD resistance and promotes the selection of optrA-positive E. faecalis clinical isolates under antibiotic pressure in a hospital setting.

Entities:  

Keywords:  linezolid resistance

Year:  2019        PMID: 30762463     DOI: 10.1089/mdr.2018.0005

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  The Impact of an Antibiotic Stewardship Program on the Consumption of Specific Antimicrobials and Their Cost Burden: A Hospital-wide Intervention.

Authors:  Dena Firouzabadi; Ali Akbari; Laleh Mahmoudi; Alireza Sepasian
Journal:  Risk Manag Healthc Policy       Date:  2020-09-23

2.  Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.

Authors:  Sarah A Egan; Anna C Shore; Brian O'Connell; Grainne I Brennan; David C Coleman
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

3.  Validating a screening agar for linezolid-resistant enterococci.

Authors:  Guido Werner; Carola Fleige; Ingo Klare; Robert E Weber; Jennifer K Bender
Journal:  BMC Infect Dis       Date:  2019-12-23       Impact factor: 3.090

4.  Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal Resistance.

Authors:  Lifang Jiang; Na Xie; Mingtao Chen; Yanyan Liu; Shuaishuai Wang; Jun Mao; Jiabin Li; Xiaohui Huang
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

5.  Antibiotic Resistance and Bacteria in Urinary Tract Infections in Pediatric Patients.

Authors:  Yakup Cag; Demet Haciseyitoglu; Abdurrahman Avar Ozdemir; Yasemin Cag
Journal:  Medeni Med J       Date:  2021-09-30

6.  Comparison of Anti-Microbic and Anti-Biofilm Activity Among Tedizolid and Radezolid Against Linezolid-Resistant Enterococcus faecalis Isolates.

Authors:  Lingbo Wang; Ying Zhang; Shixing Liu; Na Huang; Weiliang Zeng; Wenya Xu; Tieli Zhou; Mo Shen
Journal:  Infect Drug Resist       Date:  2021-11-05       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.